COVID-19 IMPACT ON 2023-2032 GLOBAL AND REGIONAL Parkinson’s Disease Therapeutics Market Size By Drug Class (Levodopa/Carbidopa, Dopamine Agonists, Adenosine A2A Antagonist, COMT Inhibitors, MAO-B Inhibitors, Glutamate Antagonist), By Route of Administration (Oral, Subcutaneous, Transdermal), By Patient (Adult, Pediatric), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027 INDUSTRY PRODUCTION
Published on: 2024-08-03 | No of Pages : 240 | Industry : Healthcare
COVID-19 IMPACT ON 2023-2032 GLOBAL AND REGIONAL
Parkinson’s Disease Therapeutics Market Size By Drug Class (Levodopa/Carbidopa, Dopamine Agonists, Adenosine A2A Antagonist, COMT Inhibitors, MAO-B Inhibitors, Glutamate Antagonist), By Route of Administration (Oral, Subcutaneous, Transdermal), By Patient (Adult, Pediatric), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027 INDUSTRY PRODUCTION
Electronic And Semiconductor
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices